Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
512
NCT01082094
Study to Evaluate the Safety of a Single Escalating Dose of ACRX-100 in Adults With Ischemic Heart Failure
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 28, 2010
Completion: Jan 31, 2012
NCT01410331
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Critical Limb Ischemia
Phase: Phase 2
Start: Mar 31, 2012
Completion: Jul 31, 2014
NCT01643590
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
Start: Jul 31, 2012
Completion: Nov 30, 2014
NCT01961726
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
Phase: Phase 1/2
Start: Oct 31, 2013
Completion: Aug 31, 2015
NCT02115568
Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203
Phase: N/A
Start: Jan 31, 2014
Completion: Jan 31, 2017
NCT02544204
SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease
Start: Nov 30, 2015
Completion: Nov 30, 2017